13F Filings History of RTW INVESTMENTS, LP

13F snapshot Latest parsed holdings, value, and filing-period context. 1 signal
Form 13F summary
  • RTW INVESTMENTS, LP Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
  • Form 13F is generally due within 45 days after each calendar quarter ends.
  • RTW INVESTMENTS, LP reported 88 equity holdings with a total reported market value of $10,049,752,600 for Q1 2026. Top reported holdings included MDGL, INSM, PTGX, PTCT, and ARGX.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
Roderick Wong - Managing Partner
Manager location
New York, NY

Follow Filing Activity

Follow RTW INVESTMENTS, LP with Pro and return when a new 13F portfolio filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Holdings Value

Form 13F evidence

Quarterly portfolio filings

SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.

Latest quarter
Q1 2026
Latest value
$10,049,752,600
Quarter delta
+$66,435,724
Accepted
15 May 2026, 08:57
Rows shown
1-25 of 49
Quarter Holdings SEC-reported value Bought Sold Net Top Holdings Form Type Accepted by SEC
Q1 2026 88 $10,049,752,600 +$1,654,726,305 -$1,123,877,965 +$530,848,340 MDGL, INSM, PTGX, PTCT, ARGX 13F-HR 15 May 2026, 08:57
Q4 2025 91 $9,983,316,876 +$2,024,357,515 -$1,656,428,920 +$367,928,595 MDGL, INSM, PTCT, ARGX, PTGX 13F-HR 17 Feb 2026, 09:45
Q3 2025 74 $8,116,139,085 +$522,672,079 -$1,183,342,481 -$660,670,402 MDGL, ARGX, RNA, PTCT, INSM 13F-HR 14 Nov 2025, 09:58
Q2 2025 73 $7,021,315,119 +$691,331,827 -$492,878,676 +$198,453,151 MDGL, NTRA, PTCT, ARGX, PTGX 13F-HR 14 Aug 2025, 08:12
Q1 2025 68 $6,538,371,722 +$547,391,786 -$500,330,799 +$47,060,987 MDGL, ARGX, PTCT, NTRA, AXSM 13F-HR 15 May 2025, 09:04
Q4 2024 72 $6,612,776,360 +$580,390,460 -$707,268,975 -$126,878,515 MDGL, ARGX, NTRA, AXSM, PTCT 13F-HR 14 Feb 2025, 09:14
Q3 2024 68 $6,911,147,155 +$541,747,712 -$396,245,916 +$145,501,796 MDGL, AXSM, RNA, ARGX, NTRA 13F-HR 14 Nov 2024, 09:09
Q2 2024 68 $6,459,165,358 +$1,007,917,015 -$750,720,834 +$257,196,181 MDGL, RCKT, AXSM, RNA, ARGX 13F-HR 14 Aug 2024, 08:50
Q1 2024 69 $6,774,577,416 +$1,115,888,358 -$1,212,839,174 -$96,950,816 RCKT, IMCR, AXSM, RARE, BRKR 13F-HR 15 May 2024, 07:43
Q4 2023 64 $6,401,901,127 +$1,002,154,062 -$360,802,235 +$641,351,827 RCKT, IMCR, MRTX, AXSM, ACAD 13F-HR 14 Feb 2024, 06:05
Q3 2023 67 $4,739,611,392 +$560,585,749 -$261,840,504 +$298,745,245 RCKT, IMCR, AXSM, ALNY, MRTX 13F-HR 14 Nov 2023, 06:09
Q2 2023 62 $5,252,749,368 +$737,528,708 -$424,947,086 +$312,581,622 IMCR, RCKT, ALNY, AXSM, PTCT 13F-HR 14 Aug 2023, 07:21
Q1 2023 60 $4,802,114,128 +$541,970,657 -$481,194,413 +$60,776,244 RXDX, PTCT, ALNY, RCKT, IMCR 13F-HR 15 May 2023, 06:26
Q4 2022 77 $4,898,669,194 +$444,473,822 -$144,521,995 +$299,951,827 ALNY, RXDX, RCKT, IMCR, TMO 13F-HR 14 Feb 2023, 08:09
Q3 2022 86 $4,337,601,000 +$240,798,822 -$319,253,223 -$78,454,401 ALNY, PTCT, RCKT, TMO, IMCR 13F-HR 14 Nov 2022, 17:10
Q2 2022 107 $3,870,392,000 +$485,807,362 -$182,109,606 +$303,697,756 ALNY, TMO, RCKT, PTCT, MASI 13F-HR 15 Aug 2022, 13:00
Q1 2022 106 $4,831,643,000 +$329,603,601 -$1,230,092,582 -$900,488,981 ALNY, RCKT, TMO, PTCT, ILMN 13F-HR 16 May 2022, 11:15
Q4 2021 124 $6,848,327,000 +$946,010,762 -$301,331,033 +$644,679,729 SPY, RCKT, ALNY, TMO, MASI 13F-HR 14 Feb 2022, 09:27
Q3 2021 120 $6,630,943,000 +$792,132,137 -$309,574,858 +$482,557,279 RCKT, SPY, ALNY, MRTX, TMO 13F-HR 15 Nov 2021, 16:46
Q2 2021 113 $6,627,028,000 +$522,303,575 -$602,319,090 -$80,015,515 RCKT, SPY, ALNY, DRNA, VCEL 13F-HR 13 Aug 2021, 16:31
Q1 2021 111 $6,405,753,000 +$1,181,310,932 -$315,040,279 +$866,270,653 RCKT, SPY, VCEL, PTCT, ALNY 13F-HR 14 May 2021, 13:01
Q4 2020 102 $5,960,264,000 +$971,207,586 -$463,116,729 +$508,090,857 RCKT, IMVT, PTCT, MRTX, STOK 13F-HR 16 Feb 2021, 14:40
Q3 2020 90 $4,153,392,000 +$628,248,373 -$107,268,515 +$520,979,858 RCKT, IMVT, ALNY, PTCT, MRTX 13F-HR 16 Nov 2020, 15:20
Q2 2020 77 $3,554,553,000 +$766,614,582 -$305,422,100 +$461,192,482 RCKT, ALNY, PTCT, DRNA, ADVM 13F-HR 14 Aug 2020, 15:18
Q1 2020 65 $2,323,157,000 +$369,962,034 -$89,043,991 +$280,918,043 RCKT, ALNY, PTCT, DRNA, BMY 13F-HR 15 May 2020, 16:19
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .